PriceTargets.com logo

Bausch Health Companies - BHC Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: C$0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 3
  • Breakdown:
  • 0 Sell Ratings
  • 3 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
C$9.65 As of 07/31/2026 05:00 PM ET
▲ +1.22 (14.47%)

This chart shows the closing price for BHC by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Bausch Health Companies Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for BHC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for BHC

Analyst Price Target is C$0.00
▼ -100.00% Downside Potential
This price target is based on 3 analysts offering 12 month price targets for Bausch Health Companies in the last 3 months. The average price target is C$0.00, with a high forecast of C$0.00 and a low forecast of C$10,000,000.00. The average price target represents a -100.00% upside from the last price of C$9.65.

This chart shows the closing price for BHC for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 3 contributing investment analysts is to hold stock in Bausch Health Companies.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
2/7/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
5/8/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
8/6/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/4/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
2/2/2026
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
5/3/2026
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
7/2/2026
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
8/1/2026

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
7/22/2026Jefferies Financial GroupUpgradeHold
12/15/2025Raymond James FinancialUpgradeHold
12/8/2025BarclaysUpgradeHold
10/15/2024EvercoreUpgradeHold
7/10/2024Raymond James FinancialUpgradeHold
2/23/2024Royal Bank Of CanadaBoost TargetSector PerformC$8.00 ➝ C$9.00
10/23/2023Royal Bank Of CanadaLower TargetSector PerformC$9.00 ➝ C$8.00
5/5/2023Royal Bank Of CanadaLower TargetSector PerformC$9.00 ➝ C$8.00
2/24/2023Royal Bank Of CanadaBoost TargetSector PerformC$8.00 ➝ C$9.00
8/8/2022GuggenheimBoost TargetC$24.00 ➝ C$26.00
2/25/2022Royal Bank Of CanadaLower TargetOutperformC$34.00 ➝ C$32.00
2/1/2022Royal Bank Of CanadaLower TargetOutperformC$43.00
(Data available from 8/1/2021 forward)

News Sentiment Rating

0.16 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 1 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
1/3/2026
  • 0 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
Mentions as of
2/2/2026
  • 1 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/4/2026
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/3/2026
  • 1 very positive mentions
  • 1 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
5/3/2026
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/2/2026
  • 0 very positive mentions
  • 0 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
7/2/2026
  • 2 very positive mentions
  • 11 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
8/1/2026

Current Sentiment

  • 2 very positive mentions
  • 11 positive mentions
  • 1 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

Bausch Health Companies logo
Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is a global diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neuroscience, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors.
Read More

Today's Range

Now: C$9.65
Low: C$8.39
High: C$9.69

50 Day Range

MA: C$7.02
Low: C$6.25
High: C$9.65

52 Week Range

Now: C$9.65
Low: C$6.10
High: C$11.97

Volume

2,060,758 shs

Average Volume

508,476 shs

Market Capitalization

C$3.60 billion

P/E Ratio

N/A

Dividend Yield

0.76%

Beta

0.973491

Frequently Asked Questions

What sell-side analysts currently cover shares of Bausch Health Companies?

The following Wall Street analysts have issued stock ratings on Bausch Health Companies in the last twelve months: Barclays PLC, Jefferies Financial Group Inc., and Raymond James Financial, Inc..
View the latest analyst ratings for BHC.

What is the current price target for Bausch Health Companies?

0 Wall Street analysts have set twelve-month price targets for Bausch Health Companies in the last year. has the lowest price target set, forecasting a price of C$10,000,000.00 for Bausch Health Companies in the next year.
View the latest price targets for BHC.

What is the current consensus analyst rating for Bausch Health Companies?

Bausch Health Companies currently has 3 hold ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in BHC, but not buy more shares or sell existing shares.
View the latest ratings for BHC.

What other companies compete with Bausch Health Companies?

Other companies that are similar to Bausch Health Companies include Aphria, Premium Brands, Aurinia Pharmaceuticals, Solaris Resources and Cara Operations. Learn More about companies similar to Bausch Health Companies.

How do I contact Bausch Health Companies' investor relations team?

Bausch Health Companies' physical mailing address is 2150 Saint-Elzear Blvd W, Laval, Quebec H7L 4A8. The company's listed phone number is 514-744-6792. The official website for Bausch Health Companies is www.valeant.com. Learn More about contacing Bausch Health Companies investor relations.